# ADIRF

## Overview
ADIRF, or adipogenesis regulatory factor, is a gene that encodes a protein involved in the regulation of adipogenic differentiation, a critical process in lipid metabolism and energy homeostasis. The protein, also referred to as adipogenesis regulatory factor, is not categorized as a kinase, receptor, or transmembrane protein, but it plays a pivotal role in promoting cell proliferation and inhibiting apoptosis, thereby influencing cell growth and survival. It is predominantly expressed in adipose tissue and is active in both the cytoplasm and nucleus, where it affects lipid storage and insulin sensitivity. The regulatory functions of ADIRF in adipogenesis and lipid metabolism underscore its potential impact on metabolic disorders when dysregulated (Jiang2021A; Liu2019Key). Additionally, its expression and function have implications in various clinical contexts, including cancer and metabolic diseases, highlighting its significance in both normal physiology and disease states (Zhou2021Discovery; Lee2020Tripartite).

## Structure


## Function
ADIRF, also known as adipogenesis regulatory factor, plays a significant role in the regulation of adipogenic differentiation, where it influences the transformation of preadipocytes into adipocytes. This process is crucial for lipid metabolism and energy homeostasis in the body. ADIRF is highly expressed in adipose tissue and its overexpression has been shown to increase the transcription of key adipogenic transcription factors such as C/EBPα and PPARγ, which are essential for adipocyte differentiation (Jiang2021A). 

In cellular biology, ADIRF is involved in promoting cell proliferation and inhibiting apoptosis, indicating its role in cell growth and survival (Jiang2021A). The protein encoded by ADIRF is active in both the cytoplasm and nucleus, where it influences lipid storage and insulin sensitivity, impacting overall metabolic health. 

ADIRF's involvement in these processes suggests its importance in maintaining normal cellular functions related to fat storage and energy balance. Its regulatory role in adipogenesis and lipid metabolism highlights its potential impact on metabolic disorders when dysregulated. The protein's activity in the cytoplasm and nucleus underscores its multifaceted role in cellular and organismal physiology.

## Clinical Significance
ADIRF (adipogenesis regulatory factor) has been identified as a significant biomarker in primary prostate cancer (PCa) through a cross-cancer learning approach. This method leverages the molecular similarities in DNA repair pathways among prostate, ovarian, and breast cancers, highlighting ADIRF's potential role in guiding clinical decision-making for PCa, particularly in aggressive tumor cases (Zhou2021Discovery).

In the context of Type 2 Diabetes Mellitus (T2DM), ADIRF is noted to be upregulated, suggesting its involvement in the disease's pathogenesis. However, specific mechanisms or interactions involving ADIRF in T2DM are not detailed, indicating a need for further research to elucidate its precise role (Liu2019Key).

The absence of ADIRF in murine models due to a genomic deletion poses challenges for translational research, as this protein is present in humans but not in mice. This species-specific expression pattern complicates the use of mouse models for studying diseases where ADIRF is implicated, such as vascular conditions (Lee2020Tripartite). Understanding these differences is crucial for improving the translational potential of preclinical studies involving ADIRF.


## References


[1. (Jiang2021A) Yu Jiang, Chen Zhang, Lujue Long, Lihua Ge, Jing Guo, Zhipeng Fan, and Guoxia Yu. A comprehensive analysis of se-lncrna/mrna differential expression profiles during chondrogenic differentiation of human bone marrow mesenchymal stem cells. Frontiers in Cell and Developmental Biology, September 2021. URL: http://dx.doi.org/10.3389/fcell.2021.721205, doi:10.3389/fcell.2021.721205. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2021.721205)

[2. (Zhou2021Discovery) Kaiyue Zhou, Suzan Arslanturk, Douglas B. Craig, Elisabeth Heath, and Sorin Draghici. Discovery of primary prostate cancer biomarkers using cross cancer learning. Scientific Reports, May 2021. URL: http://dx.doi.org/10.1038/s41598-021-89789-x, doi:10.1038/s41598-021-89789-x. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-021-89789-x)

[3. (Liu2019Key) Gao-Min Liu, Hua-Dong Zeng, Cai-Yun Zhang, and Ji-Wei Xu. Key genes associated with diabetes mellitus and hepatocellular carcinoma. Pathology - Research and Practice, 215(11):152510, November 2019. URL: http://dx.doi.org/10.1016/j.prp.2019.152510, doi:10.1016/j.prp.2019.152510. This article has 38 citations.](https://doi.org/10.1016/j.prp.2019.152510)

[4. (Lee2020Tripartite) Soo Jung Lee, Sabrina Blanchett-Anderson, Simon G. Keep, Mitchell B. Gasche, and Michael M. Wang. Tripartite factors leading to molecular divergence between human and murine smooth muscle. PLOS ONE, 15(1):e0227672, January 2020. URL: http://dx.doi.org/10.1371/journal.pone.0227672, doi:10.1371/journal.pone.0227672. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0227672)